+987.9%
MRNA vs ROL
-34.1%
+1,022.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ROL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +2.8% | +10.3% | +13.2% |
| 7D | +20.6% | +14.6% | +6.1% | +21.6% |
| 30D | +27.1% | +29.3% | -2.1% | +27.8% |
| 3M | +353.4% | +2.0% | +351.4% | +366.4% |
| 6M | +446.3% | -28.5% | +474.8% | +478.6% |
| YTD | +776.2% | -35.3% | +811.5% | +804.1% |
| 1Y | +987.9% | -34.7% | +1,022.6% | +1,013.9% |
| All | +987.9% | -34.1% | +1,022.1% | +1,013.9% |
Cumulative growth
Daily Returns
Daily percentage return beside ROL.
Daily Out/Under-Performance
Portfolio return minus ROL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ROL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ROL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling